Clot Care Images
DVT Awareness | Join Our Email List | Monday, February 08, 2010
Home
*** New Postings ***
Editorial Board
Our Supporters
Support ClotCare
Join Our Email List
Useful Web Links
DVT Coalition
CE Opportunities
Training Programs
Treatment Guidelines
Herbal Registry
Contact Us

Find Information on a:

Specific Medicine or Treatment
Type of Medicine or Treatment
Condition or Medical Procedure
Lab Test Procedure
Management Issue

View all Postings for:

Health Care Providers
Patients & Caregivers

Search ClotCare

Google
Web ClotCare

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We comply with the HONcode standard for trustworthy health
information:
verify here.

Postings on Atrial Fibrillation (A.fib. or AF)

For Patients and Caregivers

Posting Date Posted
FDA Approves Multaq (dronedarone) to Treat Heart Rhythm Disorder July, 2009
FDA advisory panel recommends approval of dronedarone March, 2009
AstraZeneca Decides to Withdraw Exanta February, 2006
Largest study yet confirms benefits of clinical pharmacy managed anticoagulation service June, 2005
FDA Rejects Ximelagatran (brand name Exanta) October, 2004
Understanding the PT-INR Test January, 2004
Understanding Atrial Fibrillation

Frequently Asked Questions Date Posted
Where can I find an anticoagulation expert near my home or office? October, 2005

For Health Care Providers

Posting Date Posted
New study and accompanying editorial suggest that warfarin may be indicated in fewer patients, but (as usual) issues remain January, 2010
FDA Approves Multaq (dronedarone) to Treat Heart Rhythm Disorder July, 2009
Review cautions acceptance of Watchman device for left atrial appendage occlusion to prevent stroke in patients with atrial fibrillation July, 2009
Atrial Fibrillation Risk Increased by Being Large at Age 20 or Gaining Weight After Age 20 June, 2009
What is the Real Scoop on Aspirin + Clopidogrel in Atrial Fibrillation? May, 2009
ATRIA Study: Reduced Renal Function and Proteinuria Are Associated with a Higher Stroke Rate in Patients with Atrial Fibrillation April, 2009
FDA advisory panel recommends approval of dronedarone March, 2009
Dronedarone reduces cardiovascular death but not total mortality (ATHENA) March, 2009
Warfarin more effective and at least as safe as low dose aspirin in elderly patients with atrial fibrillation September, 2007
Bleeding rates are higher in those over 80 years old when started on warfarin September, 2007
Should we be treating fewer patients with warfarin (Coumadin)? March, 2007
Should we be treating more patients with warfarin (Coumadin)? March, 2007
Can better INR control be achieved, and if so, how will new anticoagulants compare to warfarin (Coumadin)? March, 2007
Atrial fibrillation (AF) more than twice as prevalent as thought - and it is increasing! August, 2006
AstraZeneca Decides to Withdraw Exanta February, 2006
Major Bleeding Events Lead to Under Use of Anticoagulation in Atrial Fibrillation, but Ischemic Strokes do not Alter Prescribing Practices February, 2006
Appropriate Use of Anticoagulation in Atrial Fibrillation Patients Dramatically Increased with Availability of Anticoagulation Management Service October, 2005
Advanced age affects major bleeding and major thromboembolic rates in patients with high target INRs October, 2005
What Happened to Ximelagatran? March, 2005
New Study Supports INR of 2 to 3 for Elderly Patients with A. Fib. November, 2004
FDA Rejects Ximelagatran (brand name Exanta) October, 2004
Exanta not Recommended by FDA Advisory Panel, Causes M.I.s? September, 2004
New Supplement Devoted to Unfractionated Heparin August, 2004
LMWH Safe and Effective for A.Fib. Reversion? March, 2004
Ximelagatran (brand name Exanta) is Leading the Coming Revolution in Stroke Prevention in Atrial Fibrillation -- Two New Studies January, 2004

Frequently Asked Questions Date Posted
Where can I find an anticoagulation expert near my home or office? October, 2005
Copyright 2000-2010 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
Send comments to webmaster@clotcare.org.
ClotCare is a charitable 501(c)(3) non-profit organization. Click here to donate.
ClotCare Online Resource covers topics such as Coumadin, warfarin, blood clot, stroke, heart attack, INR, PT, low molecular weight haparin, heparin, dvt, anticoagulation, antithrombotic therapy, A. fib, atrial fibrillation, heart valve, heart valve replacement, vitamin k, AstraZeneca, Aventis, CE credit, and more.